A study to see the effect of Trivalent and Quadrivalent formulations of FluMist on the immune response of children 24 to < 48 months of age - Trial 2018-003701-26
Access comprehensive clinical trial information for 2018-003701-26 through Pure Global AI's free database. This phase not specified trial is sponsored by MedImmune LLC and is currently status unknown. The study focuses on Influenza.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2018-003701-26
Trial Details
EU Clinical Trials Register • 2018-003701-26
A study to see the effect of Trivalent and Quadrivalent formulations of FluMist on the immune response of children 24 to < 48 months of age
Study Focus
Sponsor & Location
MedImmune LLC
MedImmune, LLC
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
History of allergic disease or reactions likely to be exacerbated by any component of the investigational product;
ICD-10 Classifications
Need for immunization against influenza
Influenza and pneumonia
Influenza due to identified seasonal influenza virus
Need for immunization against plague
Influenza, virus not identified
Data Source
EU Clinical Trials Register
2018-003701-26
Non-Device Trial